IGF-1LR3 – 1mg

$135.00 – $1,300.00

IGF-1 LR3 (Insulin-like Growth Factor 1 Long R3) is a synthetic analog of insulin-like growth factor 1 (IGF-1). It differs from natural IGF-1 by the substitution of Arginine for Glutamic acid at position 3, along with an extension peptide of 13 additional amino acids at the N-terminus. This modification prolongs its half-life to approximately 20-30 hours, compared to the short half-life of natural IGF-1.

Distribution and Dosing:

Suggested dosing depends on the usage intentions and body type of the user. Reach out to us for more information.

How is this Product Used?

IGF-1 LR3 is primarily used in the fields of bodybuilding, athletics, and anti-aging for its ability to promote muscle growth, enhance recovery, and stimulate tissue repair. It acts by binding to IGF-1 receptors in various tissues, promoting protein synthesis, cell proliferation, and differentiation. This peptide is sought after for its potential to improve muscle hypertrophy, increase strength, and reduce recovery times after intense physical activity.

Positive and Negative Side Effects

Positive Side Effects

Muscle Growth: Promotes significant muscle hypertrophy and enhances muscular development.

Enhanced Recovery: Accelerates recovery times between workouts or injuries.

Fat Loss: Supports fat metabolism and aids in maintaining a lean physique.

Anti-Aging Benefits: May improve skin elasticity and reduce wrinkles.

Long Half-Life: Extended half-life allows for less frequent dosing compared to natural IGF-1.

Negative Side Effects

Injection Site Reactions: Possible discomfort, swelling, or irritation at the injection site.

Risk of Misuse: Improper dosing or administration may lead to adverse effects

Hypoglycemia

Joint Pain

Fluid Retention

Product Disclaimer

We always suggest to do your own research before making a decision on which formulas are best for you. Listening to others may put you in danger, and we always recommend for newcomers to make themselves informed of all the benefits, and side effects.